{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:28:31Z","timestamp":1770283711887,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100006315","name":"Reumafonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organization for Health Research and Development","doi-asserted-by":"crossref","award":["Vidi grant"],"award-info":[{"award-number":["Vidi grant"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1076-0","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T12:26:14Z","timestamp":1470140774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF"],"prefix":"10.1186","volume":"18","author":[{"given":"Debbie M.","family":"Boeters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter P.","family":"Nieuwenhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marije K.","family":"Verheul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elize C.","family":"Newsum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Reijnierse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 E. M.","family":"Toes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leendert A.","family":"Trouw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette H. M.","family":"van der Helm-van Mil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,2]]},"reference":[{"key":"1076_CR1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/ard.57.6.350","volume":"57","author":"F McQueen","year":"1998","unstructured":"McQueen F, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan P, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis. 1998;57:350\u20136.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/ar4035","volume":"14","author":"FM McQueen","year":"2012","unstructured":"McQueen FM. Bone marrow edema and osteitis in rheumatoid arthritis: the imaging perspective. Arthritis Res Ther. 2012;14:224.","journal-title":"Arthritis Res Ther."},{"key":"1076_CR3","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/art.22496","volume":"56","author":"E Jimenez-Boj","year":"2007","unstructured":"Jimenez-Boj E, N\u00f6bauer-Huhmann I, Hanslik-Schnabel B, Dorotka R, Wanivenhaus A-H, Kainberger F, et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum. 2007;56:1118\u201324.","journal-title":"Arthritis Rheum."},{"key":"1076_CR4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/ard.2008.096024","volume":"68","author":"N Dalbeth","year":"2009","unstructured":"Dalbeth N, Smith T, Gray S, Doyle A, Antill P, Lobo M, et al. Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease. Ann Rheum Dis. 2009;68:279\u201382.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR5","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3899\/jrheum.130902","volume":"41","author":"MP Lisbona","year":"2014","unstructured":"Lisbona MP, P\u00e0mies A, Ares J, Almirall M, Navallas M, Solano A, et al. Association of bone edema with the progression of bone erosions quantified by hand magnetic resonance imaging in patients with rheumatoid arthritis in remission. J Rheumatol. 2014;41:1623\u20139.","journal-title":"J Rheumatol."},{"key":"1076_CR6","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/art.11162","volume":"48","author":"FM McQueen","year":"2003","unstructured":"McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum. 2003;48:1814\u201327.","journal-title":"Arthritis Rheum."},{"key":"1076_CR7","doi-asserted-by":"crossref","unstructured":"Gandjbakhch F, Foltz V, Mallet A, Bourgeois P, Fautrel B. Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with lowfield MRI. Ann Rheum Dis. 2011;70:2159\u201362.","DOI":"10.1136\/ard.2010.149377"},{"key":"1076_CR8","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/rheumatology\/kel137","volume":"45","author":"K Palosaari","year":"2006","unstructured":"Palosaari K, Vuotila J, Takalo R, Jartti A, Niemel\u00e4 RK, Karjalainen A, et al. Bone oedema predicts erosive progression on wrist MRI in early RA\u2014a 2-yr observational MRI and NC scintigraphy study. Rheumatology. 2006;45:1542\u20138.","journal-title":"Rheumatology."},{"key":"1076_CR9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/ard.2007.071977","volume":"67","author":"EA Haavardsholm","year":"2008","unstructured":"Haavardsholm EA, B\u00f8yesen P, \u00d8stergaard M, Schildvold A, Kvien TK. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis. 2008;67:794\u2013800.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/ard.58.3.156","volume":"58","author":"F McQueen","year":"1999","unstructured":"McQueen F, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan P, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis. 1999;58:156\u201363.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/ard.2008.088245","volume":"68","author":"ML Hetland","year":"2009","unstructured":"Hetland ML, Ejbjerg B, H\u00f8rslev-Petersen K, Jacobsen S, Vestergaard A, Jurik AG, et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis. 2009;68:384\u201390.","journal-title":"Ann Rheum Dis"},{"key":"1076_CR12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/ard.2009.123950","volume":"70","author":"P B\u00f8yesen","year":"2011","unstructured":"B\u00f8yesen P, Haavardsholm EA, \u00d8stergaard M, van der Heijde D, Sesseng S, Kvien TK. MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are independent predictors of subsequent radiographic progression. Ann Rheum Dis. 2011;70:428\u201333.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR13","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/ar2737","volume":"11","author":"ML Mundwiler","year":"2009","unstructured":"Mundwiler ML, Maranian P, Brown DH, Silverman JM, Wallace D, Khanna D, et al. The utility of MRI in predicting radiographic erosions in the metatarsophalangeal joints of the rheumatoid foot: a prospective longitudinal cohort study. Arthritis Res Ther. 2009;11:R94.","journal-title":"Arthritis Res Ther."},{"key":"1076_CR14","doi-asserted-by":"crossref","unstructured":"Nieuwenhuis WP, van Steenbergen HW, Stomp W, Stijnen T, Huizinga TWJ, Bloem JL, et al. The Course of Bone Marrow Edema in Early Undifferentiated Arthritis and Rheumatoid Arthritis: A Longitudinal Magnetic Resonance Imaging Study at Bone Level. Arthritis Rheumatol. 2016;68:1080\u20138.","DOI":"10.1002\/art.39550"},{"key":"1076_CR15","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","volume":"43","author":"E-JJA Kroot","year":"2000","unstructured":"Kroot E-JJA, De Jong BAW, Van Leeuwen MA, Swinkels H, Van Den Hoogen FHJ, Van\u2019 t Hof M, et al. The prognostic value of anti\u2013cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000;43:1831\u20135.","journal-title":"Arthritis Rheum"},{"key":"1076_CR16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.62.2.120","volume":"62","author":"O Meyer","year":"2003","unstructured":"Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A, et al. Anticitrullinated protein\/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis. 2003;62:120\u20136.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/ard.62.5.427","volume":"62","author":"J Vencovsky","year":"2003","unstructured":"Vencovsky J, Machacek S, Sedova L, Kafkova J, Gatterova J, Pesakova V, et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis. 2003;62:427\u201330.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","volume":"63","author":"L Rycke De","year":"2004","unstructured":"De Rycke L, Peene I, Hoffman I, Kruithof E, Union A, Meheus L, et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis. 2004;63:1587\u201393.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2003.014233","volume":"63","author":"K Forslind","year":"2004","unstructured":"Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis. 2004;63:1090\u20135.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR20","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","volume":"7","author":"AH van der Helm-van Mil","year":"2005","unstructured":"van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther. 2005;7:R949\u201358.","journal-title":"Arthritis Res Ther."},{"key":"1076_CR21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/rheumatology\/kel237","volume":"46","author":"KP Machold","year":"2007","unstructured":"Machold KP, Stamm TA, Nell VPK, Pflugbeil S, Aletaha D, Steiner G, et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology. 2007;46:342\u20139.","journal-title":"Rheumatology."},{"key":"1076_CR22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/ard.2003.019992","volume":"64","author":"E Lindqvist","year":"2005","unstructured":"Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis. 2005;64:196\u2013201.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/ard.2005.041376","volume":"65","author":"E Berglin","year":"2006","unstructured":"Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA\u2010RF at disease onset. Ann Rheum Dis. 2006;65:453\u20138.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998;101:273\u201381.","journal-title":"J Clin Invest."},{"key":"1076_CR25","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest. 2012;122:1791\u2013802.","journal-title":"J Clin Invest."},{"key":"1076_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/ard.2005.04138","volume":"65","author":"M Tamai","year":"2006","unstructured":"Tamai M, Kawakami A, Uetani M, Takao S, Tanaka F, Nakamura H, et al. The presence of anti\u2010cyclic citrullinated peptide antibody is associated with magnetic resonance imaging detection of bone marrow oedema in early stage rheumatoid arthritis. Ann Rheum Dis. 2006;65:133\u20134.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR27","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3899\/jrheum.131169","volume":"41","author":"W Stomp","year":"2014","unstructured":"Stomp W, Krabben A, van der Heijde D, Huizinga TWJ, Bloem JL, Mil AHM van der H, et al. Are rheumatoid arthritis patients discernible from other early arthritis patients using 1.5 T extremity magnetic resonance imaging? A large cross-sectional study. J Rheumatol. 2014;41:1630\u20137.","journal-title":"J Rheumatol"},{"key":"1076_CR28","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","volume":"108","author":"J Shi","year":"2011","unstructured":"Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GMC, van Veelen PA, et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci USA. 2011;108:17372\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1076_CR29","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/art.1780381013","volume":"38","author":"AVD Heide","year":"1995","unstructured":"Heide AVD, Remme CA, Hofman DM, Jacobs JWG, Bijlsma JWJ. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum. 1995;38:1466\u201374.","journal-title":"Arthritis Rheum."},{"key":"1076_CR30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/annrheumdis-2012-201517","volume":"72","author":"D Aletaha","year":"2013","unstructured":"Aletaha D, Alasti F, Smolen JS. Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity. Ann Rheum Dis. 2013;72:875\u201380.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/rheumatology\/keq230","volume":"50","author":"DPC Rooy de","year":"2011","unstructured":"de Rooy DPC, van der Linden MPM, Knevel R, Huizinga TWJ, Mil AHM van der H. Predicting arthritis outcomes\u2014what can be learned from the Leiden Early Arthritis Clinic? Rheumatology. 2011;50:93\u2013100.","journal-title":"Rheumatology"},{"key":"1076_CR32","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/art.30200","volume":"63","author":"MPM Linden van der","year":"2011","unstructured":"van der Linden MPM, Batstra MR, Bakker-Jonges LE, Foundation for Quality Medical Laboratory Diagnostics, Detert J, Bastian H, et al. Toward a data-driven evaluation of the 2010 American College of Rheumatology\/European League Against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor? Arthritis Rheum. 2011;63:1190\u20139.","journal-title":"Arthritis Rheum"},{"key":"1076_CR33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum."},{"key":"1076_CR34","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s00330-014-3272-0","volume":"24","author":"W Stomp","year":"2014","unstructured":"Stomp W, Krabben A, van der Heijde D, Huizinga TWJ, Bloem JL, van der Helm-van Mil AHM, et al. Aiming for a shorter rheumatoid arthritis MRI protocol: can contrast-enhanced MRI replace T2 for the detection of bone marrow oedema? Eur Radiol. 2014;24:2614\u201322.","journal-title":"Eur Radiol."},{"key":"1076_CR35","doi-asserted-by":"publisher","unstructured":"Steenbergen HW van, Mangnus L, Reijnierse M, Huizinga TWJ, Mil AHM van der H. Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis. Ann Rheum Dis. 2015. doi: 10.1136\/annrheumdis-2015-208138 .","DOI":"10.1136\/annrheumdis-2015-208138"},{"key":"1076_CR36","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/art.39000","volume":"67","author":"WP Nieuwenhuis","year":"2015","unstructured":"Nieuwenhuis WP, Krabben A, Stomp W, Huizinga TWJ, van der Heijde D, Bloem JL, et al. Evaluation of magnetic resonance imaging-detected tenosynovitis in the hand and wrist in early arthritis. Arthritis Rheumatol Hoboken NJ. 2015;67:869\u201376.","journal-title":"Arthritis Rheumatol Hoboken NJ."},{"key":"1076_CR37","first-page":"1385","volume":"30","author":"M \u00d8stergaard","year":"2003","unstructured":"\u00d8stergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol. 2003;30:1385\u20136.","journal-title":"J Rheumatol"},{"key":"1076_CR38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1148\/radiol.2242011252","volume":"224","author":"MR Schmid","year":"2002","unstructured":"Schmid MR, Hodler J, Vienne P, Binkert CA, Zanetti M. Bone marrow abnormalities of foot and ankle: STIR versus T1-weighted contrast-enhanced fat-suppressed spin-echo MR imaging. Radiology. 2002;224:463\u20139.","journal-title":"Radiology."},{"key":"1076_CR39","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/jmri.20439","volume":"22","author":"ME Mayerhoefer","year":"2005","unstructured":"Mayerhoefer ME, Breitenseher MJ, Kramer J, Aigner N, Norden C, Hofmann S. STIR vs. T1-weighted fat-suppressed gadolinium-enhanced MRI of bone marrow edema of the knee: computer-assisted quantitative comparison and influence of injected contrast media volume and acquisition parameters. J Magn Reson Imaging. 2005;22:788\u201393.","journal-title":"J Magn Reson Imaging"},{"key":"1076_CR40","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0035-1564696","volume":"19","author":"I Sudo\u0142-Szopi\u0144ska","year":"2015","unstructured":"Sudo\u0142-Szopi\u0144ska I, Jurik AG, Eshed I, Lennart J, Grainger A, \u00d8stergaard M, et al. Recommendations of the ESSR Arthritis Subcommittee for the Use of Magnetic Resonance Imaging in Musculoskeletal Rheumatic Diseases. Semin Musculoskelet Radiol. 2015;19:396\u2013411.","journal-title":"Semin Musculoskelet Radiol."},{"key":"1076_CR41","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1136\/ard.2006.068361","volume":"66","author":"EA Haavardsholm","year":"2007","unstructured":"Haavardsholm EA, \u00d8stergaard M, Ejbjerg BJ, Kvan NP, Kvien TK. Introduction of a novel magnetic resonance imaging tenosynovitis score for rheumatoid arthritis: reliability in a multireader longitudinal study. Ann Rheum Dis. 2007;66:1216\u201320.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13075-015-0736-9","volume":"17","author":"D Aletaha","year":"2015","unstructured":"Aletaha D, Alasti F, Smolen JS. Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials. Arthritis Res Ther. 2015;17:229.","journal-title":"Arthritis Res Ther."},{"key":"1076_CR43","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/art.38307","volume":"66","author":"J Sokolove","year":"2014","unstructured":"Sokolove J, Johnson DS, Lahey LJ, Wagner CA, Cheng D, Thiele GM, et al. Rheumatoid factor as a potentiator of anti-citrullinated protein antibody mediated inflammation in rheumatoid arthritis. Arthritis Rheumatol Hoboken NJ. 2014;66:813\u201321.","journal-title":"Arthritis Rheumatol Hoboken NJ."},{"key":"1076_CR44","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1136\/annrheumdis-2014-206623","volume":"74","author":"HW Steenbergen van","year":"2015","unstructured":"van Steenbergen HW, Ajeganova S, Forslind K, Svensson B, van der Helm-van Mil AHM. The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis. Ann Rheum Dis. 2015;74:e3.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR45","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1136\/annrheumdis-2014-205428","volume":"74","author":"C Hecht","year":"2015","unstructured":"Hecht C, Englbrecht M, Rech J, Schmidt S, Araujo E, Engelke K, et al. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA. Ann Rheum Dis. 2015;74:2151\u20136.","journal-title":"Ann Rheum Dis."},{"key":"1076_CR46","doi-asserted-by":"crossref","unstructured":"Wigerblad G, Bas DB, Fernades-Cerqueira C, Krishnamurthy A, Nandakumar KS, Rogoz K, et al. Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokinedependent mechanism. Ann Rheum Dis. 2016;75:730\u20138.","DOI":"10.1136\/annrheumdis-2015-208094"},{"key":"1076_CR47","doi-asserted-by":"crossref","unstructured":"Krishnamurthy A, Joshua V, Haj Hensvold A, Jin T, Sun M, Vivar N, et al. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibodymediated bone loss. Ann Rheum Dis. 2016;75:721\u20139.","DOI":"10.1136\/annrheumdis-2015-208093"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1076-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T16:59:09Z","timestamp":1718729949000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1076-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1076"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1076-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,2]]},"article-number":"179"}}